Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Effectiveness, Tolerability, and Safety of Ectoine-Containing Mouthwash Versus Those of a Calcium Phosphate Mouthwash for the Treatment of Chemotherapy-Induced Oral Mucositis: A Prospective, Active-Controlled, Non-interventional Study

Effectiveness, Tolerability, and Safety of Ectoine-Containing Mouthwash Versus Those of a Calcium... Oral mucositis is the inflammation of the mucosa of the oral cavity. It is a frequent complication of cancer chemotherapy and radiotherapy. Approximately 20–40% of patients undergoing chemotherapy suffer from oral mucositis. It is very painful, impairs eating, drinking, and quality of life. One of the most effective yet simple measures to prevent and treat oral mucositis is oral care with mouthwash. Ectoine is a natural substance that was discovered in halophilic (salt-loving) bacteria. Ectoine can protect these bacteria against dehydration because it can attract water molecules and strengthen biological membranes. Ectoine is used to treat many diseases caused by allergens, UV light, air pollution, heat, and dryness. Ectoine (Ectoin®) mouthwash is produced by bitop AG (Dortmund, Germany) to treat dry mouth and other symptoms of inflamed oral mucosa. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Oncology and Therapy Springer Journals

Effectiveness, Tolerability, and Safety of Ectoine-Containing Mouthwash Versus Those of a Calcium Phosphate Mouthwash for the Treatment of Chemotherapy-Induced Oral Mucositis: A Prospective, Active-Controlled, Non-interventional Study

Download PDF
14 pages

Loading next page...
 
/lp/springer-journals/effectiveness-tolerability-and-safety-of-ectoine-containing-mouthwash-mMJzUQAuCS
Publisher
Springer Journals
Copyright
Copyright © 2018 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine
ISSN
2366-1070
eISSN
2366-1089
DOI
10.1007/s40487-018-0060-z
Publisher site
See Article on Publisher Site

Abstract

Oral mucositis is the inflammation of the mucosa of the oral cavity. It is a frequent complication of cancer chemotherapy and radiotherapy. Approximately 20–40% of patients undergoing chemotherapy suffer from oral mucositis. It is very painful, impairs eating, drinking, and quality of life. One of the most effective yet simple measures to prevent and treat oral mucositis is oral care with mouthwash. Ectoine is a natural substance that was discovered in halophilic (salt-loving) bacteria. Ectoine can protect these bacteria against dehydration because it can attract water molecules and strengthen biological membranes. Ectoine is used to treat many diseases caused by allergens, UV light, air pollution, heat, and dryness. Ectoine (Ectoin®) mouthwash is produced by bitop AG (Dortmund, Germany) to treat dry mouth and other symptoms of inflamed oral mucosa.

Journal

Oncology and Therapy – Springer Journals

Published: May 9, 2018

References

  • Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer
    Jones, JA; Avritscher, EB; Cooksley, CD; Michelet, M; Bekele, BN; Elting, LS
  • Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue
    Wardley, AM; Jayson, GC; Swindell, R
  • Chemotherapy-induced and/or radiation therapy-induced oral mucositis–complicating the treatment of cancer
    Naidu, MU; Ramana, GV; Rani, PU; Mohan, IK; Suman, A; Roy, P
  • MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
    Lalla, RV; Bowen, J; Barasch, A
  • Systematic review of basic oral care for the management of oral mucositis in cancer patients
    McGuire, DB; Fulton, JS; Park, J
  • The pathobiology of mucositis
    Sonis, ST
  • Oral mucositis in cancer therapy
    Sonis, ST
  • Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients
    Sonis, ST; Elting, LS; Keefe, D
  • The compatible solute ectoine protects against nanoparticle-induced neutrophilic lung inflammation
    Sydlik, U; Gallitz, I; Albrecht, C; Abel, J; Krutmann, J; Unfried, K
  • The compatible solute ectoine reduces the exacerbating effect of environmental model particles on the immune response of the airways
    Unfried, K; Kroker, M; Autengruber, A; Gotic, M; Sydlik, U
  • Reduction of neutrophilic lung inflammation by inhalation of the compatible solute ectoine: a randomized trial with elderly individuals
    Unfried, K; Kramer, U; Sydlik, U
  • Carbon nanoparticles induce ceramide- and lipid raft-dependent signalling in lung epithelial cells: a target for a preventive strategy against environmentally-induced lung inflammation
    Peuschel, H; Sydlik, U; Grether-Beck, S
  • c-Src-mediated activation of Erk1/2 is a reaction of epithelial cells to carbon nanoparticle treatment and may be a target for a molecular preventive strategy
    Peuschel, H; Sydlik, U; Haendeler, J
  • Recovery of neutrophil apoptosis by ectoine: a new strategy against lung inflammation
    Sydlik, U; Peuschel, H; Paunel-Gorgulu, A
  • Ultraviolet A-induced signaling involves a ceramide-mediated autocrine loop leading to ceramide de novo synthesis
    Grether-Beck, S; Timmer, A; Felsner, I; Brenden, H; Brammertz, D; Krutmann, J
  • Biophysical investigations of the structure and function of the tear fluid lipid layers and the effect of ectoine. Part B: artificial lipid films
    Dwivedi, M; Brinkkotter, M; Harishchandra, RK; Galla, HJ
  • The effect of compatible solute ectoines on the structural organization of lipid monolayer and bilayer membranes
    Harishchandra, RK; Wulff, S; Lentzen, G; Neuhaus, T; Galla, HJ
  • Novel effects of ectoine, a bacteria-derived natural tetrahydropyrimidine, in experimental colitis
    Abdel-Aziz, H; Wadie, W; Abdallah, DM; Lentzen, G; Khayyal, MT
  • Efficacy and tolerability of an ectoine mouth and throat spray compared with those of saline lozenges in the treatment of acute pharyngitis and/or laryngitis: a prospective, controlled, observational clinical trial
    Müller, D; Lindemann, T; Shah-Hosseini, K
  • Noninterventional open-label trial investigating the efficacy and safety of ectoine containing nasal spray in comparison with beclomethasone nasal spray in patients with allergic rhinitis
    Sonnemann, U; Moller, M; Bilstein, A
  • Treatment of allergic rhinitis with ectoine containing nasal spray and eye drops in comparison with azelastine containing nasal spray and eye drops or with cromoglycic acid containing nasal spray
    Werkhäuser, N; Bilstein, A; Sonnemann, U
  • Sunitinib in patients with metastatic renal cell carcinoma
    Motzer, RJ; Rini, BI; Bukowski, RM
  • Efficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment of oral mucositis in patients receiving high-dose cancer therapy: a review of current data
    Quinn, B
  • Caphosol(®) mouthwash gives no additional protection against oral mucositis compared to cryotherapy alone in stem cell transplantation. A pilot study
    Svanberg, A; Ohrn, K; Birgegard, G
  • A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer
    Wong, KH; Kuciejewska, A; Sharabiani, MT
  • Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation
    Treister, N; Nieder, M; Baggott, C
  • Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancer
    Rao, NG; Trotti, A; Kim, J
  • DNA protection by ectoine from ionizing radiation: molecular mechanisms
    Hahn, MB; Meyer, S; Schroter, MA; Kunte, HJ; Solomun, T; Sturm, H
  • Ectoine protects DNA from damage by ionizing radiation
    Schroter, MA; Meyer, S; Hahn, MB; Solomun, T; Sturm, H; Kunte, HJ